SFX by Ex Libris Inc.

Title:	Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome
Source:	Nature Genetics [1061-4036] Niihori, Tetsuya yr:2006

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Schubbert, S. "Germline KRAS mutations cause Noonan syndrome." Nature genetics 38.3 (2006): 331-336.
description	2.	Rodriguez-Viciana, P. "Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome." Science 311.5765 (2006): 1287-90.
description	3.	Hartigan, J. "The Consensus Coding Sequences of Human Breast and Colorectal Cancers." Science 314.5797 (2006): 268-74.
description	4.	Narumi, Y. "Molecular and clinical characterization of cardio-facio-cutaneous (CFC) syndrome: overlapping clinical manifestations with Costello syndrome." American journal of medical genetics. Part A 143A.8 (2007): 799-807.
description	5.	Patton, E Elizabeth E. "BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma." Current biology 15.3: 249-254.
description	6.	Wood, Laura D D. "The Genomic Landscapes of Human Breast and Colorectal Cancers." Science 318.5853 (2007): 1108-1113.
description	7.	Noonan, Jacqueline A A. "Noonan syndrome and related disorders: Alterations in growth and puberty." Reviews in endocrine & metabolic disorders 7.4 (2007): 251-5.
description	8.	Carta, C. "Germline missense mutations affecting KRAS isoform B are associated with a severe noonan syndrome phenotype." American journal of human genetics 79.1 (2006): 129-135.
description	9.	Montgomery, K. "Germline gain-of-function mutations in SOS1 cause Noonan syndrome." Nature genetics 39.1 (2007): 70-4.
description	10.	Neri, T. "The cardiofaciocutaneous syndrome." Journal of medical genetics . 43.11 (2006): 833-42.
description	11.	Cohen, P. "Insulin-like growth factors and their binding proteins in children born small for gestational age: implication for growth hormone therapy." Hormone research 60 Suppl 3 (2003): 115-23.
description	12.	Lamb, J. "The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease." Science 313.5795 (2006): 1929-35.
description	13.	Strauss, Bernard S. "Limits to the Human Cancer Genome Project?" Science 315.5813 (2007): 762-6.
description	14.	Kinzler, Kenneth W W. "Cancer genes and the pathways they control." Nature medicine 10.8 (2004): 789-99.
description	15.	Armour, C M M. "Further delineation of cardio-facio-cutaneous syndrome: clinical features of 38 individuals with proven mutations." Journal of medical genetics 45.4 (2008): 249-54.
description	16.	Cha, T. "Akt-mediated phosphorylation of EZH2 augments methylation of lysine 27 in histone H3." Science 310.5746 (2005): 306-310.
description	17.	Garg, V. "GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5." Nature 424.6947 (2003): 443-7.
description	18.	Clements, J. "Patterns of somatic mutation in human cancer genomes." Nature 446.7132 (2007): 153-8.
description	19.	Shamash, David M. "Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway." Blood 105.3 (2005): 1214-21.
description	20.	Stern, Leonard I M. "Cancer genetics and drug discovery in the zebrafish." Nature reviews. Cancer 3.7 (2003): 533-9.